{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:25:14Z","timestamp":1788323114663,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnologia","doi-asserted-by":"publisher","award":["CB-253891"],"award-info":[{"award-number":["CB-253891"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.humimm.2026.111815","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:00:19Z","timestamp":1784761219000},"page":"111815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL10 promoter variants in neurocysticercosis: Family-based susceptibility and exploratory genotype-phenotype analyses in Mexican case-parent trios"],"prefix":"10.1016","volume":"87","author":[{"given":"M.","family":"Villegas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fleury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Alaez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Gorodezky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Sciutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2026.111815_bb0005","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/S1286-4579(00)01336-8","article-title":"Taenia solium disease in humans and pigs: an ancient parasitosis disease rooted in developing countries and emerging as a major health problem of global dimensions","volume":"2","author":"Sciutto","year":"2000","journal-title":"Microbes Infect."},{"issue":"7","key":"10.1016\/j.humimm.2026.111815_bb0010","first-page":"830","article-title":"Symptomatic human neurocysticercosis--age, sex and exposure factors relating with disease heterogeneity","volume":"251","author":"Fleury","year":"2004","journal-title":"J. Neurol."},{"key":"10.1016\/j.humimm.2026.111815_bb0015","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.clim.2005.04.008","article-title":"Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles","volume":"116","author":"Chavarr\u00eda","year":"2005","journal-title":"Clin. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111815_bb0020","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.trstmh.2010.01.005","article-title":"Clinical heterogeneity of human neurocysticercosis results from complex interactions among parasite, host and environmental factors","volume":"104","author":"Fleury","year":"2010","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"9","key":"10.1016\/j.humimm.2026.111815_bb0025","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/01.inf.0000233548.81204.97","article-title":"Neurocysticercosis: clinical, radiologic, and inflammatory differences between children and adults","volume":"25","author":"S\u00e1enz","year":"2006","journal-title":"Pediatr. Infect. Dis. J."},{"key":"10.1016\/j.humimm.2026.111815_bb0030","series-title":"Neurocysticercosis: A clinical handbook","author":"Del Brutto","year":"1998"},{"key":"10.1016\/j.humimm.2026.111815_bb0035","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S1474-4422(14)70094-8","article-title":"Clinical symptoms, diagnosis, and treatment of neurocysticercosis","volume":"13","author":"Garcia","year":"2014","journal-title":"Lancet Neurol."},{"issue":"6","key":"10.1016\/j.humimm.2026.111815_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005646","article-title":"Extraparenchymal neurocysticercosis: demographic, clinicoradiological, and inflammatory features","volume":"11","author":"Marcin Sierra","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.humimm.2026.111815_bb0045","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.pt.2020.07.003","article-title":"Could differences in infection pressure be involved in cysticercosis heterogeneity?","volume":"36","author":"Hamamoto Filho","year":"2020","journal-title":"Trends Parasitol."},{"issue":"12","key":"10.1016\/j.humimm.2026.111815_bb0050","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S1286-4579(03)00206-5","article-title":"TH2 profile in asymptomatic Taenia solium human neurocysticercosis","volume":"5","author":"Chavarr\u00eda","year":"2003","journal-title":"Microbes Infect."},{"key":"10.1016\/j.humimm.2026.111815_bb0055","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000068748","article-title":"High prevalence of calcified silent neurocysticercosis in a rural village of Mexico","volume":"22","author":"Fleury","year":"2003","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.humimm.2026.111815_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.trstmh.2005.08.008","article-title":"An epidemiological study of familial neurocysticercosis in an endemic Mexican community","volume":"100","author":"Fleury","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.humimm.2026.111815_bb0065","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0020-7519(03)00206-6","article-title":"Population genetic structure of Taenia solium from Madagascar and Mexico: implications for clinical profile diversity and immunological technology","volume":"33","author":"Vega","year":"2003","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.humimm.2026.111815_bb0070","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1645\/GE-2786RN","article-title":"Detection of genetic variation in Taenia solium","volume":"89","author":"Maravilla","year":"2003","journal-title":"J. Parasitol."},{"key":"10.1016\/j.humimm.2026.111815_bb0075","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.micinf.2005.11.005","article-title":"A depressed peripheral cellular immune response is related to symptomatic neurocysticercosis","volume":"8","author":"Chavarria","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.humimm.2026.111815_bb0080","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.humimm.2018.04.011","article-title":"No association of IL2, IL4, IL6, TNF, and IFNG gene polymorphisms was found with Taenia solium human infection or neurocysticercosis severity in a family-based study","volume":"79","author":"Fleury","year":"2018","journal-title":"Hum. Immunol."},{"issue":"4","key":"10.1016\/j.humimm.2026.111815_bb0085","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00430-011-0198-x","article-title":"Immune response in symptomatic and asymptomatic neurocysticercosis","volume":"200","author":"Verma","year":"2011","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.humimm.2026.111815_bb0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00430-011-0207-0","article-title":"Neurocysticercosis: local and systemic immune-inflammatory features related to severity","volume":"201","author":"S\u00e1enz","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.humimm.2026.111815_bb0095","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/cei.12709","article-title":"Interleukin 10 and dendritic cells are the main suppression mediators of regulatory T cells in human neurocysticercosis","volume":"183","author":"Arce-Sillas","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"9","key":"10.1016\/j.humimm.2026.111815_bb0100","doi-asserted-by":"crossref","first-page":"e326","DOI":"10.1093\/cid\/ciaa1128","article-title":"The local inflammatory profile and predictors of treatment success in subarachnoid neurocysticercosis","volume":"72","author":"Harrison","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.humimm.2026.111815_bb0105","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202154096","article-title":"Helminthic dehydrogenase drives PGE2 and IL-10 production in monocytes to potentiate Treg induction","volume":"23","author":"Prodjinotho","year":"2022","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.humimm.2026.111815_bb0110","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200320","article-title":"Immunologic profiling of CSF in subarachnoid neurocysticercosis reveals specific Interleukin-10-producing cell populations during treatment","volume":"11","author":"Tang","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"issue":"2","key":"10.1016\/j.humimm.2026.111815_bb0115","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1007\/s12035-024-04377-0","article-title":"Efficiency of Cysticidal therapy impacted by the host\u2019s immune response in neurocysticercosis patients","volume":"62","author":"Mehta","year":"2025","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.humimm.2026.111815_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2026.153162","article-title":"Differential astrocyte activation by Taenia solium antigens: specific induction of IL-10 and IL-1\u03b2 by excretory\/secretory (ES) products","volume":"231","author":"Gonzales","year":"2026","journal-title":"Immunobiology"},{"key":"10.1016\/j.humimm.2026.111815_bb0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-immunol-031210-101312","article-title":"Regulation and functions of the IL-10 family of cytokines in inflammation and disease","volume":"29","author":"Ouyang","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.humimm.2026.111815_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.femsim.2004.06.006","article-title":"IL-10 gene polymorphisms in infectious disease and SIDS","volume":"42","author":"Opdal","year":"2004","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.humimm.2026.111815_bb0135","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10238-014-0315-4","article-title":"Association of interleukin-10 promoter haplotypes with disease susceptibility and IL-10 levels in Mexican patients with systemic lupus erythematosus","volume":"15","author":"Palafox-S\u00e1nchez","year":"2015","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.humimm.2026.111815_bb0140","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1128\/IAI.00261-12","article-title":"Interleukin-10 polymorphisms are associated with IL-10 production and clinical malaria in young children","volume":"80","author":"Zhang","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.humimm.2026.111815_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2370.1997.tb00001.x","article-title":"An investigation of polymorphism in the interleukin-10 gene promoter","volume":"24","author":"Turner","year":"1997","journal-title":"Eur. J. Immunogenet."},{"key":"10.1016\/j.humimm.2026.111815_bb0150","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1089\/gtmb.2012.0100","article-title":"Distribution of the IL-1RN, IL-6, IL-10, INF-\u03b3, and TNF-\u03b1 gene polymorphisms in the Mexican population","volume":"16","author":"Vargas-Alarc\u00f3n","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"4","key":"10.1016\/j.humimm.2026.111815_bb0155","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15048411","article-title":"Frequency distribution of interleukin-10 haplotypes (\u22121082 a>G, \u2212819 C>T, and \u2212592 C>a) in a Mexican population","volume":"15","author":"V\u00e1zquez-Villamar","year":"2016","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.humimm.2026.111815_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004013","article-title":"Interleukin-10 -1082 G\/a gene polymorphisms in Egyptian children with CAP: a case-control study","volume":"95","author":"Azab","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.humimm.2026.111815_bb0165","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1128\/CVI.00334-13","article-title":"Haplotypes of the IL10 gene as potential protection factors in leprosy patients","volume":"20","author":"Garc\u00eda","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"issue":"1","key":"10.1016\/j.humimm.2026.111815_bb0170","first-page":"50","article-title":"Interleukin-10 (IL-10) 1082 promoter polymorphisms and plasma IL-10 levels in patients with bacterial sepsis","volume":"59","author":"Vivas","year":"2021","journal-title":"Rom. J. Intern. Med."},{"issue":"12","key":"10.1016\/j.humimm.2026.111815_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24780","article-title":"Association of polymorphisms in the IL-10 promoter region with Crohn\u2019s disease","volume":"36","author":"Sun","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.humimm.2026.111815_bb0180","doi-asserted-by":"crossref","DOI":"10.1177\/03946320241240705","article-title":"Impact of IL-10 gene promoter polymorphisms on treatment response in HCV patients: a systematic review, a meta-analysis, and a meta-regression","volume":"38","author":"Dhaouadi","year":"2024","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.humimm.2026.111815_bb0185","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ana.24732","article-title":"New diagnostic criteria for neurocysticercosis: reliability and validity","volume":"80","author":"Carpio","year":"2016","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.humimm.2026.111815_bb0190","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13073-021-00835-9","article-title":"CADD-splice\u2014improving genome-wide variant effect prediction using deep learning-derived splice scores","volume":"13","author":"Rentzsch","year":"2021","journal-title":"Genome Med."},{"key":"10.1016\/j.humimm.2026.111815_bb0195","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41588-023-01365-3","article-title":"Annotating and prioritizing human non-coding variants with RegulomeDB v.2","volume":"55","author":"Dong","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humimm.2026.111815_bb0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1471-2105-9-290","article-title":"SNPAnalyzer 2.0: a web-based integrated workbench for linkage disequilibrium analysis and association analysis","volume":"9","author":"Yoo","year":"2008","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"10.1016\/j.humimm.2026.111815_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0004143","article-title":"A comparative study of peripheral immune responses to Taenia solium in individuals with parenchymal and subarachnoid neurocysticercosis","volume":"9","author":"Tuero","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"4","key":"10.1016\/j.humimm.2026.111815_bb0210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008005","article-title":"Host immune responses during Taenia solium neurocysticercosis infection and treatment","volume":"14","author":"Prodjinotho","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"2","key":"10.1016\/j.humimm.2026.111815_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013937","article-title":"Taenia solium neurocysticercosis: its current epidemiological, diagnostic, therapeutic, and control landscapes","volume":"20","author":"Bustos","year":"2026","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.humimm.2026.111815_bb0220","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00347-19","article-title":"Association of TRAF1\/C5 locus polymorphisms with epilepsy and clinical traits in Mexican neurocysticercosis patients","volume":"87","author":"Villegas","year":"2019","journal-title":"Infect. Immun."},{"key":"10.1016\/j.humimm.2026.111815_bb0225","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/656395","article-title":"Toll-like receptor 4 polymorphism and its association with symptomatic neurocysticercosis","volume":"202","author":"Verma","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.humimm.2026.111815_bb0230","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jneuroim.2014.07.018","article-title":"Association of ICAM-1 K469E polymorphism with neurocysticercosis","volume":"276","author":"Singh","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.humimm.2026.111815_bb0235","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1007\/s12035-016-9779-4","article-title":"Human glutathione S-transferase enzyme gene polymorphisms and their association with neurocysticercosis","volume":"54","author":"Singh","year":"2017","journal-title":"Mol. Neurobiol."}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926001618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885926001618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:11:47Z","timestamp":1788322307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885926001618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0198885926001618"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111815","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL10 promoter variants in neurocysticercosis: Family-based susceptibility and exploratory genotype-phenotype analyses in Mexican case-parent trios","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2026.111815","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Histocompatibility and Immunogenetics.","name":"copyright","label":"Copyright"}],"article-number":"111815"}}